The Effect of Home-Based Monitoring, Exercise Training
1 other identifier
interventional
40
1 country
1
Brief Summary
Chronic obstructive pulmonary disease (COPD); From time to time, significant involvement in dusts or gases and abnormal disease outbreaks are observed, which are observed throughout life in the period when the cause has just emerged, interruption of air flow with disruptions in air flow, shortness of breath, increase in the amount of secretion. Directly or indirectly, very high costs are incurred in COPD care and promotion. While mild stages are treated without directed hospitalization, hospitalizations become more frequent as the disease progresses, and the duration of hospitalization in each acute attack increases compared to the next attack. Acute exacerbations of COPD negatively affect the rates of rehospitalization and emergency service admissions, and the living conditions of this condition, whose long-term cause of death and morbidity has not yet been revealed, do not lead to negative aspects. Exercise programs applied in chronic diseases should include stopping their illnesses, increasing sleep during the disease, stopping inflammatory acuteness, and in addition to treatment, the rest of the patients should be normal. It has been stated that it is more effective than home-based hospital system applications in pulmonary regulation, and it has been taken positively from applications compatible with the basic field, as everywhere in the world. In this direction, the effect of home-based monitoring, education and exercise training applied to individuals with COPD via tele-consultancy method on repeated hospitalization and quality of life is revealed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 2, 2023
CompletedFirst Posted
Study publicly available on registry
November 13, 2023
CompletedNovember 13, 2023
November 1, 2023
1.1 years
November 2, 2023
November 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
repeated hospitalizations
after randomization and 12 weeks later
They will be questioned about the number of times they were admitted to hospital due to COPD during 12 weeks.
Secondary Outcomes (1)
Quality of life that COPD patients
Their quality of life will be evaluated with the SF-36 quality of life (Short Form) immediately after randomization and 12 weeks later.
Study Arms (2)
intervention group
EXPERIMENTALCOPD patients
Control group
NO INTERVENTIONCOPD patients
Interventions
Eligibility Criteria
You may qualify if:
- Agreeing to participate in the research,
- Diagnosed with COPD,
- Able to use a smartphone,
- Oriented and cooperative,
- Does not have a psychiatric disorder that impairs verbal communication, such as schizophrenia or dementia,
- Having no communication problems.
You may not qualify if:
- Having alcohol or drug addiction,
- Those with physical disabilities,
- Illiterate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ordu Universitylead
Study Sites (1)
Nejla KOKSAL
Ordu, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 2, 2023
First Posted
November 13, 2023
Study Start
May 1, 2022
Primary Completion
May 30, 2023
Study Completion
May 30, 2023
Last Updated
November 13, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share